TP53 and esophageal squamous cell carcinoma: A more recent whole exome sequencing and multi-omics study comparing Japanese ESCC and EAC patient samples also confirmed that TP53 was the most common driver mutation with somatic mutations detected in 88.6% and 62.5% of the ESCC and EAC patient tumor tissue, respectively [80].